Phase 2 study for people with Leukaemia

Recruiting Phase 2

Sources: ClinicalTrials.gov Checked: 11 October 2026 Not medical advice

This trial at a glance

Status Recruiting
Phase Phase 2
Sponsor Lin BioScience, Inc
Registry number NCT05756322
Started 20 July 2023 Today 16 October 2026 Estimated completion 31 December 2026

Where this trial is running

Trial sites and the status recorded for each
SiteCityState or countryStatus at this site
Wollongong Private Hospital Wollongong NSW Completed
Pindara Private Hospital Benowa QLD Completed
The Royal Adelaide Hospital Adelaide SA Recruiting
The Alfred Hospital Melbourne VIC Active not recruiting
Hollywood Private Hospital Nedlands Australia Withdrawn
Q Medical Conselling Perth WA Withdrawn

voxsanity.com.au · trial sites from public registries · registry record synced 11 October 2026 · not medical advice

Who can join

Age 18 Years to 120 Years
Sex Anyone, regardless of sex
Healthy volunteers Not accepted
Enrolment target 90

The official eligibility criteria

Registry text, reproduced exactly. These are the words the trial's sponsor published on ClinicalTrials.gov. They have not been edited, shortened or rewritten, and they are written for researchers rather than for patients.

Inclusion Criteria:

* Male or female subjects greater than 18 years old, inclusive.

* Pathologically confirmed diagnoses of Relapsed or resistant AML or ALL.

* Patients who are ineligible for standard therapies that are anticipated to result in durable remission or cure, or who have no known therapy options of documented benefit.

* Eastern Cooperative Oncology Group (ECOG) performance status 0 to 2.

Exclusion Criteria:

* Concomitant chemotherapy, radiation therapy, or immunotherapy.

* Receiving any other investigational agents concurrently or within 30 days prior to screening.

* Patient has acute promyelocytic leukaemia or leukemia with active CNS involvement.

* History of another active malignancy with 2 years prior to study entry, basal cell skin cancer and previous carcinoma in treated curatively.

* Patient with mental deficits and/or psychiatric history that precludes them from giving informed consent or from following protocol.

Dates on the record

Started 20 July 2023
Estimated completion 31 December 2026
Registry last updated 27 March 2026
Checked by Voxsanity 11 October 2026

Results, publications and the official record

Sources and dates

  • ClinicalTrials.gov – the record this page reformats
  • ClinicalTrials.gov processing date: 27 March 2026.
  • This page last checked by Voxsanity: 11 October 2026.

Voxsanity reformats data from public registries into this layout. It does not edit, interpret or add to what the registry published.

Not medical advice.

Individual trial records are refreshed on a rolling basis rather than all at once, so a record may be up to several weeks old. Each trial page and trial card shows the date its own record was last synced. Where a record has lagged, its status, sites and enrolment can differ from the current registry state in either direction, so check the registry link on the trial page before acting on them.

Letter for your doctor

A one-page summary of this trial to print or email to your GP. It carries the registry's own record of the trial and its eligibility criteria, and nothing Voxsanity has written about whether it suits you.